Pharming Group
PHAR
9 hedge funds and large institutions have $857K invested in Pharming Group in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
125% more funds holding
Funds holding: 4 → 9 (+5)
36% more capital invested
Capital invested by funds: $630K → $857K (+$228K)
0% less ownership
Funds ownership: 0.09% → 0.09% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$18.1K |
| 2 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$3.15K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.25K |
| 4 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$286 |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
+$37 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$20K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SBCM
1
Silverberg Bernstein Capital Management
Armonk,
New York
| $756K | – | – | – |
|
|
2
Morgan Stanley
New York
| $63.1K | +$18.1K | +1,455 | +50% |
|
|
EWA
3
EverSource Wealth Advisors
Birmingham,
Alabama
| $20K | -$20K | -1,602 | -54% |
|
|
NSG
4
Nalls Sherbakoff Group
Knoxville,
Tennessee
| $12.6K | – | – | – |
|
|
NA
5
NewEdge Advisors
New Orleans,
Louisiana
| $3.67K | +$3.15K | +253 | New |
|
|
6
BNP Paribas Financial Markets
Paris,
France
| $1.45K | +$1.25K | +100 | New |
|
|
GRP
7
Global Retirement Partners
San Rafael,
California
| $334 | +$286 | +23 | New |
|
|
SS
8
SBI Securities
Tokyo,
Japan
| $29 | +$25 | +2 | New |
|
|
9
Bessemer Group
Woodbridge,
New Jersey
| – | +$37 | +3 | New |
|
PHAR Hedge Fund Activity: Q3 2025 in Review
9 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q3 2025, worth a combined $857K — up 36% from $630K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PHAR positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $18.1K. The largest seller was EverSource Wealth Advisors, cutting an estimated $20K.
- 9 institutional investors held Pharming Group (PHAR) as of Q3 2025, up from 4 in Q2 2025.
- Funds reported $857K of Pharming Group stock for Q3 2025, up 36% quarter-over-quarter.
- 5 funds opened new Pharming Group positions in Q3 2025 and 0 closed out, a net change of +5 holders.
- The largest Pharming Group buyer in Q3 2025 was Morgan Stanley, an estimated $18.1K added.
- The largest Pharming Group seller in Q3 2025 was EverSource Wealth Advisors, an estimated $20K sold.
Based on aggregated 13F filings for Q3 2025.